Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata

Journal of Neurochemistry

Volumn 76, Issue 3, 2001, Pages 815-824

  Furukawa, Nobuya ^a   Arai, Nobutaka ^b   Goshima, Yoshio ^a   Miyamae, Takeaki ^a   Ohshima, Etsuo ^c   Suzuki, Fumio ^c   Fujita, Kiyohide ^a   Misu, Yoshimi ^a,d  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

^d Shinobu Hospital   (Japan)

Author keywords

Brain ischemia; Competitive DOPA antagonist; Delayed neuronal cell death; DOPA cyclohexyl ester; DOPA release; Glutamate release

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPA; DOPA ANTAGONIST; DOPA CYCLOHEXYL ESTER; DOPAMINE; GLUTAMIC ACID; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CANNULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY;

ANIMALS; CELL DEATH; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPAMINE; ENZYME INHIBITORS; GLUTAMIC ACID; HYDRAZINES; ISCHEMIC ATTACK, TRANSIENT; LEVODOPA; MALE; NEURONS; RATS; RATS, WISTAR; TIME FACTORS;

ANIMALIA;

EID: 0035125530     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00068.x     Document Type: Article

References (49)

1. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons
2. Glutamate neurotoxicity and diseases of the nervous system
3. Is DOPA itself an endogenous potentiator for glutamate release by ischemia in rat striata?
4. Is L-DOPA an endogenous potentiator for glutamate release and resultant neuronal death by transient ischemia in rats?
5. L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compounds in rats
6. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil
7. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis
8. Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices
9. Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices
10. L-Dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices
11. Picomolar concentrations of L-DOPA stereoselectively potentiate activities of presynaptic β-adrenoceptors to facilitate the release of endogenous noradrenaline from rat hypothalamic slices
12. 2+-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices
13. L-DOPA induces concentration- dependent facilitation and inhibition of presynaptic acetylcholine release in the guinea-pig submucous plexus
14. Delayed neuronal death in the gerbil hippocampus following ischemia
15. Evidence of N-methyl-D-aspartate receptor- mediated modulation of the aortic baroreceptor reflex in the rat nucleus tractus solitarii
16. Evidence for L-DOPA systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat
17. Excitatory amino acids as a final common pathway for neurologic disorders
18. L-DOPA neurotoxicity is mediated by glutamate release in cultured rat striatal neurons
19. Endogenously released DOPA itself is a causal factor for increase in glutamate release and delayed neuronal cell death induced by transient ischemia in rats
20. Is L-DOPA an endogenous neurotransmitter?
21. Presynaptic β-adrenoceptors
22. Biphasic actions of L-dopa on the release of endogenous dopamine via presynaptic receptors in rat striatal slices
23. Neurobiology of L-DOPAergic systems
24. L-DOPA cyclohexyl ester is a novel stable and potent competitive antagonist against L-DOPA, as compared to L-DOPA methyl ester
25. Some interactions of L-DOPA and its related compounds with glutamate receptors
26. L-DOPAergic components in the caudal ventrolateral medulla in baroreflex neurotransmission
27. +-evoked release of 3,4-dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis
28. 2 receptor-mediated locomotor activities of conscious rats
29. Isradipine, a calcium channel blocker, attenuates the ischemia-induced release of dopamine but not glutamate in rats
30. An L-DOPAergic relay from the posterior hypothalamic nucleus to the rostral ventrolateral medulla and its cardiovascular function in anesthetized rats
31. Extracellular neurotransmitter changes in cerebral ischaemia
32. Brain lesions in an infant rhesus monkey treated with monosodium glutamate
33. Ischemia-induced changes in extracellular levels of striatal cyclic AMP: Role of dopamine neurotransmission
34. Pathophysiology of acute ischaemic stroke
35. Temporal profile of neuronal damage in a model of transient forebrain ischemia
36. Evidence that glutamic acid is the neurotransmitter of baro-receptor afferent terminating in the nucleus tractus solitarius (NTS)
37. 2-adrenoceptor- but not facilitatory angiotensin II receptor-mediated modulation of noradrenaline release from rat hypothalamic slices
38. Selective vulnerability of the hippocampus in brain ischemia
39. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo (F) quinoxaline: A neuroprotectant for cerebral ischemia
40. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis
41. Evidence for L-glutamate as the neurotransmitter of baroreceptor afferent nerve fibers
42. Endogenous L-DOPA in the rat dorsal vagal complex: An immunocytochemical study by light and electron microscopy
43. L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats
44. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis
45. 2 receptor-mediated locomotor activities of conscious rats
46. Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic function in the nucleus tractus solitarii of rats
47. Altered tonic L-3,4-dihydroxyphenylalanine systems in the nucleus tractus solitarii and the rostral ventrolateral medulla of spontaneously hypertensive rats
48. Continuous monitoring and regulating of brain temperature in the conscious and freely moving ischemic gerbil: Effect of MK-801 on delayed neuronal death in hippocampal CA1